Pharmacokinetic mismatch does not lead to emergence of isoniazid- or rifampin-resistant Mycobacterium tuberculosis but to better antimicrobial effect: a new paradigm for antituberculosis drug scheduling.

Pharmacokinetic mismatch does not lead to emergence of isoniazid- or rifampin-resistant Mycobacterium tuberculosis but to better antimicrobial effect: a new paradigm for antituberculosis drug scheduling.

Item

http://www.wikidata.org/entity/Q35364313

Q35364313

about

Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in tuberculosis.Ethambutol pharmacokinetic variability is linked to body mass in overweight, obese, and extremely obese people.Outwitting evolution: fighting drug-resistant TB, malaria, and HIV.TB and HIV Therapeutics: Pharmacology Research Priorities.Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy.Poor Penetration of Antibiotics Into Pericardium in Pericardial Tuberculosis.A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests.Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo.Partnerships to Design Novel Regimens to Treat Childhood Tuberculosis, Sui Generis: The Road Ahead.Rifampicin mono-resistant tuberculosis in France: a 2005-2010 retrospective cohort analysis.Pharmacologic considerations in use and development of antituberculosis drugs.Nonclinical models for antituberculosis drug development: a landscape analysis.Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes.Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis.Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments.A programme to create short-course chemotherapy for pulmonary Mycobacterium avium disease based on pharmacokinetics/pharmacodynamics and mathematical forecasting.Pharmacokinetic mismatch of tuberculosis drugs.Reply to “Pharmacokinetic Mismatch of Tuberculosis Drugs”.Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?Translational Modeling of Antibacterial Agents

P2860

Q33621748-F27E28AA-D6BF-4553-A75B-6CBA4ABFFD71 Q34922554-90D46402-B190-4DC1-BDB3-FCB2CDE8FE28 Q35806375-456949AD-8D46-4115-8E27-2807979A7EB2 Q35878689-C83B1CAC-3B92-42C2-9C29-16973D02B991 Q36099838-1C04959A-54E8-4DB1-878A-DE378FFE2E3D Q36379388-A3F6BDDF-3CC2-4FD2-8A32-CAED8B106874 Q36540893-EACD7D1B-C0CC-4204-8D8A-1CD88D51C38F Q36869913-B0945D5F-A4EB-46FC-B2DA-0B4B17AE2B41 Q37287830-0DE8ECEC-1AA8-4EE1-B9C5-A8E2948CEC37 Q37339268-8698DF08-F69F-42E2-BD62-850BBB735055 Q37339276-0F306445-27AC-4A26-AF0B-0738154584EC Q37339294-4BE412E5-2F41-4653-94DC-BBE2C20ABE8F Q37502309-D5B88B2D-94D2-4DB6-B5CA-3710D539F06D Q38252559-35689B83-581C-4E32-9EFF-D2B24473E2DE Q38502294-A51FE24A-A24E-42C2-B8DF-ADF1CAA563A7 Q38979626-FC39555A-2F77-4BF5-A151-C235F7858E29 Q40184248-3676EBF1-78AC-4607-987B-FC2C2314D7E0 Q41082086-BC65AB20-766B-43AB-BD98-589507A37ED0 Q41996871-7BE01CC9-1A1A-4170-9D23-7DA7878877AE Q42598452-FB096F81-8ECE-4C40-907E-0341C52BA0E2 Q45828861-1B7F20E6-4030-4DE4-B0CC-C8209CE5901E Q47332682-35B88174-D0CC-4C63-B0AB-8BAEA20C804E Q57240408-5DE60BFB-7968-42EF-A45C-D3FB71599989

P2860

Pharmacokinetic mismatch does not lead to emergence of isoniazid- or rifampin-resistant Mycobacterium tuberculosis but to better antimicrobial effect: a new paradigm for antituberculosis drug scheduling.

Item

http://www.wikidata.org/entity/Q35364313

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu